about
Neurobiology of aversive states.Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted ratsMetabolic changes in the rodent brain after acute administration of salvinorin A.Peptide kappa opioid receptor ligands: potential for drug development.Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.A cell-based, high-throughput homogeneous time-resolved fluorescence assay for the screening of potential κ-opioid receptor agonists.The role of kappa-opioid receptor activation in mediating antinociception and addiction.PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivoDrug dependence: neuropharmacology and management.Butorphanol suppression of histamine itch is mediated by nucleus accumbens and septal nuclei: a pharmacological fMRI studyTranscriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptorEffect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat.Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus.Epigenetic suppression of GAD65 expression mediates persistent painState-dependent opioid control of pain.Sex differences in opioid analgesia: clinical and experimental findings.Effects of combined opioids on pain and mood in mammals.Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats.Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid rewardCellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.Opioid system in the medial prefrontal cortex mediates binge-like eatingκ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites.Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cellsRewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapsesAnalyzing Interaction of μ-, δ- and κ-opioid Receptor Gene Variants on Alcohol or Drug Dependence Using a Pattern Discovery-based Method.Therapy of pruritus.Targeted treatment of pruritus: a look into the futureNalfurafine hydrochloride for the treatment of pruritus.Investigational drugs for pruritus.The role of the opioid system in alcohol dependence.Atopic dermatitis-associated protein interaction network lead to new insights in chronic sulfur mustard skin lesion mechanisms.Does the kappa opioid receptor system contribute to pain aversion?Kappa Opioid Receptor Agonist and Brain Ischemia.Involvement of kappa opioid receptors in the formalin-induced inhibition of analgesic tolerance to morphine via suppression of conventional protein kinase C activation.Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.κ-opioid receptor as a key mediator in the regulation of appetitive 50-kHz ultrasonic vocalizations.
P2860
Q27687846-286BF66C-AEDF-4501-B0A8-AD80503BE853Q28566486-F111F972-4B7D-41BD-BA6F-172CC71C1C5CQ30490227-A14A7A55-FAE7-419F-84A1-7D5586174D91Q33442900-BA093FE9-E617-4E53-9153-E98924EC00C2Q33727027-1C5EDDE7-062B-4D45-9634-5CB9C9401B12Q33806664-98645CA9-24D8-4559-A39D-1F1537999A30Q33824673-348F8187-CD41-4080-AC2E-3471FD542EDFQ33869693-0E8CDE04-78B6-4C4E-B446-B3B27FE7C14AQ34132638-08E668BE-2AB7-41BD-A6B7-A7BD2F5C1C9FQ34540741-600A68B0-7DCF-4B1F-B3AB-84CEF7603E49Q34773986-4066F504-FF26-4CCA-B6E2-6B9DFA7B21BEQ34899400-D17CBFFD-41E6-4D96-BDA5-0D0568064C4FQ35044062-EF26116D-C6A6-44AE-8D19-15CAFBA56923Q35190847-2CC6EA29-0AD1-47DB-BE10-8F455F214BDBQ35358687-4B900436-3BA2-4A75-9187-E1C669A9C95EQ35535806-F73E66D4-A6D0-463D-88C3-CCCCF4D308CBQ35811910-82C29F79-7C82-4FFA-ADE3-C4993708CB4BQ35868750-B9E8A420-21FF-411D-B7ED-C9EB7E871E55Q35884913-4FFBBEFC-AAF5-4D62-82B9-1E9C6EAE0123Q36186158-7D84AC55-91F5-45BC-906A-26AE59ADB279Q36403790-C3E3BD3F-7D98-4484-804A-3290E664E5B4Q36741881-6F87BC03-6C1F-4C8A-800F-48224A0A9FCCQ36758556-C29B4A4E-34A5-45EC-A095-2A4C69400512Q36876266-DD5F3497-260B-47FF-BD8A-1D198ECF5811Q36935317-536C71AA-9B68-4C56-9B46-2C22E9D31D0BQ36946620-A97E0AF7-DFBB-4B1F-91F0-59811D1C368AQ37162162-57007DBF-D6FB-4AF5-83FE-9D15EEB5B2A2Q37579300-DA5B152E-0023-452C-8E86-8508BF08E50EQ37738911-45C75821-5974-4B25-BE8B-05927A233289Q37827172-D9791DCD-23E0-4F59-858A-53622E7F9A77Q38015897-37BE4529-D9B1-4BC8-B9DF-C2901584ABA7Q38118383-F6256C80-23ED-42D6-A43C-A65A5FF87319Q38139197-4E3F08BA-B70C-400E-B6F2-BA27436A486EQ38151762-0D75F86B-93B5-442D-81E5-12385B27BC78Q38276410-3FDFDBDB-CFD2-4028-907E-7EEA48485797Q38312641-771778FE-DD11-4E02-A150-1EBF2B24FC78Q38342129-DE361D03-2AB8-4F64-96B8-29ECE939295AQ38452688-1098FFFB-522F-4B41-A8BA-DEB0E870346DQ41268502-EA23719F-CC11-4890-B89A-F993CC22DA9DQ41735843-B815AE55-D83E-4B7A-A8EA-87077AC1B4CA
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
mu-Opposing actions of the kappa-opioid receptor
@ast
mu-Opposing actions of the kappa-opioid receptor
@en
mu-Opposing actions of the kappa-opioid receptor
@nl
type
label
mu-Opposing actions of the kappa-opioid receptor
@ast
mu-Opposing actions of the kappa-opioid receptor
@en
mu-Opposing actions of the kappa-opioid receptor
@nl
prefLabel
mu-Opposing actions of the kappa-opioid receptor
@ast
mu-Opposing actions of the kappa-opioid receptor
@en
mu-Opposing actions of the kappa-opioid receptor
@nl
P1476
mu-Opposing actions of the kappa-opioid receptor
@en
P2093
P356
10.1016/S0165-6147(98)01169-9
P407
P577
1998-03-01T00:00:00Z